CHANTIX (Avera McKennan Hospital)
Welcome to the PulseAid listing for the CHANTIX drug offered from Avera McKennan Hospital. This Partial Cholinergic Nicotinic Agonist [EPC],Partial Cholinergic Nicotinic Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | varenicline tartrate |
SUBSTANCE NAME: | VARENICLINE TARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Partial Cholinergic Nicotinic Agonist [EPC],Partial Cholinergic Nicotinic Agonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-01-22 |
END MARKETING DATE: | 0000-00-00 |
CHANTIX HUMAN PRESCRIPTION DRUG Details:
Item Description | CHANTIX from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2016-01-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0492_e019fbcd-8038-4b99-91fe-e94adec0650d |
PRODUCT NDC: | 69189-0492 |
APPLICATION NUMBER: | NDA021928 |
Other VARENICLINE TARTRATE Pharmaceutical Manufacturers / Labelers: